Last $106.21 USD
Change Today -0.31 / -0.29%
Volume 336.1K
CVD On Other Exchanges
New York
As of 8:04 PM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

210 Carnegie Center

Princeton, NJ 08540

United States

Phone: 609-452-4440

Fax: 609-452-9375

as well as non-GLP (Good Laboratory Practice) toxicology, in vivo pharmacology, imaging services, and biomarker services. The company provides GLP and non-GLP biomarker services, and offers bioimaging capabilities and cardiac related biomarkers for animals and humans. The company formed a Biomarker Center of Excellence dedicated to the development, validation, and testing of biomarkers. Bioanalytical Services: The company’s bioanalytical testing services, which are conducted in its bioanalytical laboratory in Indianapolis, Indiana and in its immunoanalytical facility in Chantilly, Virginia, as well as in its laboratories in Madison, Wisconsin; Harrogate, the United Kingdom; and Shanghai, China, help determine the appropriate dose and frequency of drug application from late discovery evaluation through Phase III clinical testing on a full-scale, globally integrated basis. Clinical Pharmacology Services The company provides clinical pharmacology services, including first-in-human trials, and early patient proof of concept studies of new pharmaceuticals at its four clinics located throughout the United States and its clinic in Leeds, the United Kingdom. LATE-STAGE DEVELOPMENT SERVICES This segment includes central laboratory, Phase II-IV clinical development, and market access services. Central Laboratory Services The company provides central laboratory services. It has four central laboratories, one in each of the United States, Switzerland, Singapore, and China that provide central laboratory services to biotechnology and pharmaceutical customers. The company also has an alliance for central laboratory services testing in Japan with BML, Inc., a Japanese laboratory testing company. The company’s capabilities provide clients the flexibility to conduct studies on a multinational and simultaneous basis. The data that it provides is combinable and results in global clinical trial reference ranges. The company also employs a proprietary clinical trials management system that enables the company to enter a sponsor's protocol requirements directly into its database. The laboratory data could be audited because all laboratory data could be traced to source documents. In addition, the laboratories are capable of delivering customized data electronically within 24 hours of test completion. The company also offers pharmacogenomic testing and sample storage technologies in conjunction with its central laboratory services. Central laboratory services also offers LabLink, an Internet-based client access program that allows clients to review and query clinical trial lab data on a near real-time basis; and the Covance Local Laboratories service, which uses a proprietary system to harmonize laboratory results from local and regional laboratories to help expand the reach of traditional central laboratory services. The company’s central laboratories have an automated kit production line that is located in the United States and supplies kits to investigator sites around the world. In 2013, the company introduced an automated kit receipt line in its United States central laboratory. It has also automated various lab testing procedures. In 2013, the company commenced offering companion diagnostic services, which support the parallel development of a new medicine and its companion diagnostic assay, and external laboratory management services, which help clients select, qualify, contract with and manage outside laboratories. Clinical Development Services The company offers a range of clinical trial services, including the management of Phase II through IV clinical studies. It has experience in the majority of therapeutic areas, and provides various core services either on an individual or aggregated basis to meet clients' needs, such as study design and modeling; coordination of study activities; trial logistics; monitoring of study site performance; clinical data management and biostatistical analysis; and medical writing and regulatory services. The company manages clinical trials in the North America, Europe, South America, and the Asia Pacific regions. It could manage every aspect of clinical trials


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CVD:US $106.21 USD -0.31

CVD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Catalent Inc $27.62 USD -0.10
IMS Health Holdings Inc $24.61 USD -0.47
PAREXEL International Corp $60.96 USD -0.55
Quintiles Transnational Holdings Inc $60.50 USD -1.26
STERIS Corp $65.22 USD -1.27
View Industry Companies

Industry Analysis


Industry Average

Valuation CVD Industry Range
Price/Earnings 34.0x
Price/Sales 2.3x
Price/Book 3.6x
Price/Cash Flow 19.3x
TEV/Sales 2.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact COVANCE INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at